📖

Semaglutide Phase 3 Alzheimer's Trial (EVOKE Plus, NCT04777409)

active
wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-nct04777409
Related Entities
clinical-trials-nct04777409
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
24
Outgoing
31
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (55)
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Cytochrome Therapeutics70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Cytochrome Therapeutics70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
related🧪Digital Twin-Guided Metabolic Reprogramming50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪Phase-Separated Organelle Targeting50%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%
related🔬What are the most promising therapeutic strategies for targe50%
related🧪Trans-Synaptic Adhesion Molecule Modulation50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🧪Perforant Path Presynaptic Terminal Protection Strategy50%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the most promising therapeutic strategies for targe40%
related🧪Stress Granule Phase Separation Modulators40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
related🧪Phase-Separated Organelle Targeting40%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%

💬 Discussion